California, US AI start-up Profluent has signed a major alliance with pharma group Eli Lilly, worth up to $2.25 billion, that ...

Automation is key to ensuring long-term success. Embracing automation is a critical business decision; it will streamline ...

GSK's antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, has started a speedy FDA review that should deliver a ...

Novartis has started to show the effects of its patent cliff more strongly, with sales and profits falling in the first ...

After years of wrangling, OxyContin manufacturer Purdue Pharma is on the brink of a bankruptcy agreement that could allow it ...

Results from a late-stage trial of Boehringer Ingelheim and Zealand Pharma's GLP-1 and glucagon agonist drug survodutide ...

As a tech lover, I soak it all in and leave inspired about what’s next. This was the case recently when I attended Google ...

Merck KGaA has started working with Remepy on the development of hybrid drugs that combine a medicine with digital ...

In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with John Holodnak, co-founder of Occam, about how AI is ...

From effective panellist recruitment and robust validation, to precision targeting and enhanced engagement, discover how a ...

A court ruling in the US has delivered a setback for GSK and its Tesaro subsidiary in their dispute with AnaptysBio over ...

The launch of a new national research collaboration focused on Parkinson’s disease has been announced. The Parkinson’s ...